Vimta Labs through its diagnostic and pathological services business has recorded a revenue of Rs. 30 crores during FY 2024 and Rs. 7 crores in Q1 FY 2025
The company is making its mark through strategic initiatives, promising to become a significant presence in the evolving pharmaceutical sector
The study highlighted substantial improvements in key clinical parameters among RA patients who underwent AWS intervention
The partnership will provide health plans with an out-of-the-box compliance solution for CMS-9115 and CMS-0057 rules
The grant is designated for the research and development of Pyronaridine
This partnership aims to accelerate research and development into innovative treatments and, if successful, will generate milestones and royalties
Stringent regulatory environments can make OEMs reluctant to change processes and materials for approved medical devices
The tele-icu services which had a soft launch four months ago have already provided valuable assistance to 250+ patients in some of the remotest villages in India
These digital initiatives are expected to enhance the accessibility and efficiency of drug safety monitoring and standards compliance
Subscribe To Our Newsletter & Stay Updated
